EXETER, N.H.--(BUSINESS WIRE)--Oct. 25, 2005--Bentley Pharmaceuticals, Inc. (NYSE:BNT), a technology-based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, today announced that it will release its 2005 third quarter results for the three and nine months ended September 30, 2005 after the market closes on Wednesday, November 2, 2005.
